NCT05284565

Brief Summary

Clinical trial with the aim to evaluate the level of agreement in wheal size measures in allergy skin prick testing (SPT) between the electro-medical device Nexkin DSPT® and the manual measurement procedure used in the daily practice.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
93

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 27, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 27, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 25, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 17, 2022

Completed
Last Updated

April 24, 2023

Status Verified

April 1, 2023

Enrollment Period

2 months

First QC Date

February 25, 2022

Last Update Submit

April 21, 2023

Conditions

Keywords

skin prick testallergyskin testingSPT3D imagingallergy testingallergy test readingautomatic measurement

Outcome Measures

Primary Outcomes (1)

  • Agreement in wheal size measures in allergy skin testing between the electro-medical device Nexkin DSPT and the manual measurement procedure

    Fifteen minutes after the punctures have been performed, a double reading of the forearm shall be taken with the device. The first reading will be stored for later analysis, and the second reading will be used afterwards. The healthcare professional will then perform the manual reading and generate the manual result sheet as is standard practice. The health professional visually examines the forearm and compares his observation with the identification presented by the device. The result of the identifications made by the device as well as the interactions of the healthcare professional on the screen shall be recorded on the device. Diameter measurements are measured in millimetres (mm) and area measurements are measured in square millimetres (mm2).

    5 minutes

Secondary Outcomes (2)

  • Test-retest reliability of device reading.

    5 minutes

  • Variability in measurements of histamine wheals made by different health professionals.

    5 minutes

Study Arms (1)

Results of reading

OTHER

All patients who were prick tested and accepted to participate in the study, were prospectively included in the study in only one arm. All of their tests were read by the device and the manual procedure.

Device: Reading of the skin prick allergy test

Interventions

A double reading of the forearm will be performed with the Nexkin DSPT device. Also, two healthcare professionals will perform, consecutively, the manual reading according to their usual practice. Nexkin DSPT device provides a semi-automatic wheal detection, presenting the user an initial set of potential wheals and information about them (as their measure). Healthcare professional can then discard, add and/or confirm wheals by visual validation, and add/edit wheal information. The device automates the test reading process, digitises the results, and quantifies.

Results of reading

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patient to be tested with aeroallergen and/or food battery prick tests.
  • Patient over 12 years of age.
  • Patient, or his/her representative, who has given consent to participate in the study.
  • Patient who has not taken an antihistamine for more than 3 days.
  • Women of childbearing age who, at the time of taking the clinical history, declare that they are not pregnant.

You may not qualify if:

  • Patients who are to be tested with a prick number greater than 40.
  • Patients who are to be tested with a prick number less than 40, but for whom it is necessary to place more than two rows of allergens in at least one of the arms.
  • Patients who have taken an antihistamine within the previous 3 days.
  • Patients who are being treated with antidepressants or other drugs with an antihistamine effect.
  • Patients who suffer severe atopic dermatitis affecting the forearms.
  • Patients with dermographism.
  • Patients who are to undergo intradermal testing.
  • Pregnant women or women suspected of pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinica Universidad de Navarra, Universidad de Navarra

Pamplona, Navarre, 31008, Spain

Location

Related Publications (3)

  • Justo X, Diaz I, Gil JJ, Gastaminza G. Medical Device for Automated Prick Test Reading. IEEE J Biomed Health Inform. 2018 May;22(3):895-903. doi: 10.1109/JBHI.2017.2680840. Epub 2017 Mar 9.

    PMID: 28362597BACKGROUND
  • Justo X, Diaz I, Gil JJ, Gastaminza G. Prick test: evolution towards automated reading. Allergy. 2016 Aug;71(8):1095-102. doi: 10.1111/all.12921. Epub 2016 May 20.

    PMID: 27100940BACKGROUND
  • Morales-Palacios MP, Nunez-Cordoba JM, Tejero E, Matellanes O, Quan PL, Carvallo A, Sanchez-Fernandez S, Urtasun M, Larrea C, Iniguez MT, Gimenez R, Goikoetxea MJ, D'Amelio CM, Ferrer M, Gastaminza G. Reliability of a novel electro-medical device for wheal size measurement in allergy skin testing: An exploratory clinical trial. Allergy. 2023 Jan;78(1):299-301. doi: 10.1111/all.15474. Epub 2022 Aug 20. No abstract available.

    PMID: 35950712BACKGROUND

MeSH Terms

Conditions

Hypersensitivity

Condition Hierarchy (Ancestors)

Immune System Diseases

Study Officials

  • Gabriel Gastaminza Lasarte, Dr.

    Clinica Universidad de Navarra, Universidad de Navarra

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: The study will prospectively include patients attending the Allergology Department, after signing an informed consent form and a data protection clause.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2022

First Posted

March 17, 2022

Study Start

May 20, 2021

Primary Completion

July 27, 2021

Study Completion

July 27, 2021

Last Updated

April 24, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations